BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 33928029)

  • 1. Radiomics Analysis of PET and CT Components of
    Wang X; Lu Z
    Front Oncol; 2021; 11():638124. PubMed ID: 33928029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a
    Liu H; Cui Y; Chang C; Zhou Z; Zhang Y; Ma C; Yin Y; Wang R
    BMC Cancer; 2024 Jan; 24(1):150. PubMed ID: 38291351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma.
    Nie P; Yang G; Wang N; Yan L; Miao W; Duan Y; Wang Y; Gong A; Zhao Y; Wu J; Zhang C; Wang M; Cui J; Yu M; Li D; Sun Y; Wang Y; Wang Z
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):217-230. PubMed ID: 32451603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of
    Ma J; Guo D; Miao W; Wang Y; Yan L; Wu F; Zhang C; Zhang R; Zuo P; Yang G; Wang Z
    Abdom Radiol (NY); 2022 Apr; 47(4):1244-1254. PubMed ID: 35218381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of
    Song Y; Tian Y; Lu X; Chen G; Lv X
    Med Phys; 2024 Jan; ():. PubMed ID: 38252704
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Xu X; Sun X; Ma L; Zhang H; Ji W; Xia X; Lan X
    Front Oncol; 2023; 13():1149791. PubMed ID: 36969043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiomics in Gastric Cancer: First Clinical Investigation to Predict Lymph Vascular Invasion and Survival Outcome Using
    Yang L; Chu W; Li M; Xu P; Wang M; Peng M; Wang K; Zhang L
    Front Oncol; 2022; 12():836098. PubMed ID: 35433451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiomics-clinical nomogram based on pretreatment 18F-FDG PET-CT radiomics features for individualized prediction of local failure in nasopharyngeal carcinoma.
    Ding J; Li Z; Lin Y; Huang C; Chen J; Hong J; Fei Z; Zhou Q; Chen C
    Sci Rep; 2023 Oct; 13(1):18167. PubMed ID: 37875498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of
    Luo Y; Huang Z; Gao Z; Wang B; Zhang Y; Bai Y; Wu Q; Wang M
    Korean J Radiol; 2024 Feb; 25(2):189-198. PubMed ID: 38288898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of platinum resistance for advanced high-grade serous ovarian carcinoma using MRI-based radiomics nomogram.
    Li H; Cai S; Deng L; Xiao Z; Guo Q; Qiang J; Gong J; Gu Y; Liu Z
    Eur Radiol; 2023 Aug; 33(8):5298-5308. PubMed ID: 36995415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation.
    Fang S; Lai L; Zhu J; Zheng L; Xu Y; Chen W; Wu F; Wu X; Chen M; Weng Q; Ji J; Zhao Z; Tu J
    Front Mol Biosci; 2021; 8():662366. PubMed ID: 34532340
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnostic Value of
    Feng L; Yang X; Lu X; Kan Y; Wang C; Zhang H; Wang W; Yang J
    Acad Radiol; 2023 May; 30(5):940-951. PubMed ID: 36117128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs.
    Yang L; Xu P; Li M; Wang M; Peng M; Zhang Y; Wu T; Chu W; Wang K; Meng H; Zhang L
    Front Oncol; 2022; 12():894323. PubMed ID: 35800046
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Xue XQ; Yu WJ; Shi X; Shao XL; Wang YT
    Front Oncol; 2022; 12():911168. PubMed ID: 36003788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiomics Analysis of PET and CT Components of PET/CT Imaging Integrated with Clinical Parameters: Application to Prognosis for Nasopharyngeal Carcinoma.
    Lv W; Yuan Q; Wang Q; Ma J; Feng Q; Chen W; Rahmim A; Lu L
    Mol Imaging Biol; 2019 Oct; 21(5):954-964. PubMed ID: 30671740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel analytic approach for outcome prediction in diffuse large B-cell lymphoma by [
    Zhang X; Chen L; Jiang H; He X; Feng L; Ni M; Ma M; Wang J; Zhang T; Wu S; Zhou R; Jin C; Zhang K; Qian W; Chen Z; Zhuo C; Zhang H; Tian M
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1298-1310. PubMed ID: 34651227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating manual diagnosis into radiomics for reducing the false positive rate of
    Kang F; Mu W; Gong J; Wang S; Li G; Li G; Qin W; Tian J; Wang J
    Eur J Nucl Med Mol Imaging; 2019 Dec; 46(13):2770-2779. PubMed ID: 31321483
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Hu S; Kang Y; Xie Y; Yang T; Yang Y; Jiao J; Zou Q; Zhang H; Zhang Y
    Abdom Radiol (NY); 2023 Feb; 48(2):532-542. PubMed ID: 36370179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra- and peritumoral radiomics for predicting early recurrence in patients with high-grade serous ovarian cancer.
    Wu Y; Jiang W; Fu L; Ren M; Ai H; Wang X
    Abdom Radiol (NY); 2023 Feb; 48(2):733-743. PubMed ID: 36445408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of an
    Wang H; Zhao S; Li L; Tian R
    Eur Radiol; 2020 Oct; 30(10):5578-5587. PubMed ID: 32435928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.